Global Vinpocetine Market Growth 2025-2031

Global Vinpocetine Market Growth 2025-2031

The global Vinpocetine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis

Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.

LP Information, Inc. (LPI) ' newest research report, the “Vinpocetine Industry Forecast” looks at past sales and reviews total world Vinpocetine sales in 2024, providing a comprehensive analysis by region and market sector of projected Vinpocetine sales for 2025 through 2031. With Vinpocetine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vinpocetine industry.

This Insight Report provides a comprehensive analysis of the global Vinpocetine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vinpocetine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vinpocetine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vinpocetine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vinpocetine.

This report presents a comprehensive overview, market shares, and growth opportunities of Vinpocetine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Tablet
Injection

Segmentation by Application:
Household
Hospital

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vinpocetine market?

What factors are driving Vinpocetine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vinpocetine market opportunities vary by end market size?

How does Vinpocetine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.